GN Store Nord A/S (GGNDF)
USD 18.05
(0.0%)
USD 18.05
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.94 Billion DKK | -2.05% |
| 2022 | 9.13 Billion DKK | 5.18% |
| 2021 | 8.68 Billion DKK | 18.96% |
| 2020 | 7.29 Billion DKK | -3.75% |
| 2019 | 7.58 Billion DKK | 26.94% |
| 2018 | 5.97 Billion DKK | 9.56% |
| 2017 | 5.45 Billion DKK | 11.52% |
| 2016 | 4.88 Billion DKK | 14.6% |
| 2015 | 4.26 Billion DKK | -5.95% |
| 2014 | 4.53 Billion DKK | 10.28% |
| 2013 | 4.11 Billion DKK | 10.3% |
| 2012 | 3.72 Billion DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.18 Billion DKK | -11.15% |
| 2024 Q2 | 2.24 Billion DKK | 2.79% |
| 2023 Q3 | 2.22 Billion DKK | 0.09% |
| 2023 FY | 8.94 Billion DKK | -2.05% |
| 2023 Q1 | 2.04 Billion DKK | -20.58% |
| 2023 Q2 | 2.22 Billion DKK | 8.87% |
| 2023 Q4 | 2.45 Billion DKK | 10.52% |
| 2022 FY | 9.13 Billion DKK | 5.18% |
| 2022 Q2 | 2.42 Billion DKK | 34.26% |
| 2022 Q1 | 1.8 Billion DKK | -14.8% |
| 2022 Q4 | 2.57 Billion DKK | 10.35% |
| 2022 Q3 | 2.32 Billion DKK | -4.0% |
| 2021 Q2 | 2.05 Billion DKK | -1.01% |
| 2021 Q4 | 2.12 Billion DKK | 2.32% |
| 2021 Q3 | 2.07 Billion DKK | 0.93% |
| 2021 FY | 8.68 Billion DKK | 18.96% |
| 2021 Q1 | 2.07 Billion DKK | -4.86% |
| 2020 Q1 | 1.66 Billion DKK | -22.96% |
| 2020 Q2 | 1.34 Billion DKK | -19.6% |
| 2020 Q3 | 2.09 Billion DKK | 56.45% |
| 2020 Q4 | 2.18 Billion DKK | 3.96% |
| 2020 FY | 7.29 Billion DKK | -3.75% |
| 2019 Q4 | 2.16 Billion DKK | 18.44% |
| 2019 Q3 | 1.82 Billion DKK | -0.38% |
| 2019 FY | 7.58 Billion DKK | 26.94% |
| 2019 Q1 | 1.75 Billion DKK | -10.74% |
| 2019 Q2 | 1.83 Billion DKK | 4.62% |
| 2018 Q4 | 1.96 Billion DKK | 23.82% |
| 2018 Q3 | 1.58 Billion DKK | -0.63% |
| 2018 Q2 | 1.59 Billion DKK | 12.07% |
| 2018 FY | 5.97 Billion DKK | 9.56% |
| 2018 Q1 | 1.42 Billion DKK | -16.86% |
| 2017 Q1 | 1.37 Billion DKK | -13.27% |
| 2017 FY | 5.45 Billion DKK | 11.52% |
| 2017 Q2 | 1.49 Billion DKK | 8.34% |
| 2017 Q3 | 1.42 Billion DKK | -4.89% |
| 2017 Q4 | 1.71 Billion DKK | 20.62% |
| 2016 Q1 | 1.18 Billion DKK | -14.15% |
| 2016 FY | 4.88 Billion DKK | 14.6% |
| 2016 Q4 | 1.59 Billion DKK | 18.04% |
| 2016 Q3 | 1.34 Billion DKK | 5.65% |
| 2016 Q2 | 1.27 Billion DKK | 7.23% |
| 2015 FY | 4.26 Billion DKK | -5.95% |
| 2015 Q4 | 1.38 Billion DKK | 23.44% |
| 2015 Q3 | 1.12 Billion DKK | 3.51% |
| 2015 Q2 | 1.08 Billion DKK | -6.39% |
| 2015 Q1 | 1.15 Billion DKK | -12.54% |
| 2014 Q3 | 1.08 Billion DKK | -1.72% |
| 2014 Q1 | 1.02 Billion DKK | -13.16% |
| 2014 Q4 | 1.32 Billion DKK | 22.03% |
| 2014 FY | 4.53 Billion DKK | 10.28% |
| 2014 Q2 | 1.1 Billion DKK | 7.92% |
| 2013 Q4 | 1.17 Billion DKK | 20.57% |
| 2013 Q1 | 936 Million DKK | -11.45% |
| 2013 Q2 | 1.02 Billion DKK | 9.19% |
| 2013 Q3 | 977 Million DKK | -4.4% |
| 2013 FY | 4.11 Billion DKK | 10.3% |
| 2012 Q4 | 1.05 Billion DKK | 17.84% |
| 2012 FY | 3.72 Billion DKK | 0.0% |
| 2012 Q3 | 897 Million DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -1000.00 USD | 894500100.0% |
| Össur hf. | 485.57 Million USD | -1742.153% |
| QHSLab, Inc. | 793.6 Thousand USD | -1127032.195% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -1742.153% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | -173717.844% |
| Aurora Spine Corporation | 8.21 Million USD | -108835.354% |
| BrainsWay Ltd. | 23.09 Million USD | -38638.036% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -21357.332% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -25396.388% |
| BioElectronics Corporation | 466.38 Thousand USD | -1917830.993% |
| Vivos Inc. | -6036.00 USD | 148194268.323% |
| Kelyniam Global, Inc. | 2.03 Million USD | -439225.016% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 4579740.694% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 1182145.593% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -53321.403% |
| Avitar, Inc. | 836.7 Thousand USD | -1068978.358% |
| Nanomix Corporation | -69.45 Thousand USD | 12878386.159% |
| Theraclion SA | -1.08 Million USD | 828045.593% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -1522323.624% |
| NewCardio, Inc. | 105.1 Thousand USD | -8510599.029% |
| Positron Corporation | -353.46 Thousand USD | 2530760.744% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -855467.405% |
| Lombard Medical, Inc. | 955 Thousand USD | -936549.215% |
| ALR Technologies Inc. | 4945.00 USD | -180889687.664% |
| Stratec SE | 71.58 Million USD | -12394.997% |
| Vycor Medical, Inc. | 1.31 Million USD | -679790.001% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 69341185.271% |
| MicroPort Scientific Corporation | 532.09 Million USD | -1581.081% |
| VMS Rehab Systems, Inc. | -10.44 USD | 85680076728.352% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -24847122.222% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -3330403.615% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -15805462.427% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -62178.076% |
| IR-Med Inc. | -17 Thousand USD | 52617747.059% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -4333318.92% |
| United American Healthcare Corporation | -8000.00 USD | 111812600.0% |
| Polarean Imaging plc | 335.48 Thousand USD | -2666204.999% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -817506.556% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -508520.68% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 2824619.8% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -1253672.179% |
| Urologix, Inc. | 6.09 Million USD | -146707.812% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | -128.713% |
| NIOX Group Plc | 28.13 Million USD | -31695.061% |
| Fuse Medical, Inc. | 10.73 Million USD | -83234.591% |
| Broncus Holding Corporation | 7.22 Million USD | -123671.966% |
| Brain Scientific Inc. | 54.32 Thousand USD | -16465615.601% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -1118637.509% |
| Health Logic Interactive Inc. | - USD | -Infinity% |